What is Aurinia Pharmaceuticals Inc?
, a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.97B, and a P/E ratio of 6.4x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 223,806 shares $380k | 0 |
| 3-6months | 120,975 shares $356k | 5814,606 shares $12.5M |
| 6-9months | 0 | 6900,000 shares $12.7M |
| 9-12months | 0 | 0 |